Natalia Carrillo-López

University of Oviedo

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (8)

Manuel A Fernandez-Rodriguez

Associate Professor

Universidad de Alcalá

SPAIN

View details

Juan F. Navarro-González

Chief, Research Division

Servicio Canario de Salud

SPAIN

View details

Armando Torres

Emeritus Professor

Universidad de la Laguna

SPAIN

View details

GUILLERMO MARIÑO GARCÍA

Professor

University of Oviedo

SPAIN

View details

SONIA MOTA

Universidad de Extremadura

SPAIN

View details

Laura Vicente Vicente

Profesor Contratado Doctor

Universidad de Salamanca

SPAIN

View details

Julio Alvarez-Builla

Professor of Organic Chemistry

Universidad de Alcalá

SPAIN

View details

Marcos Perez

Profesor Asociado

University of Oviedo

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Natalia Carrillo-López

Research Interests

Explore related searches

Contact this professor

Articles (10)

Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes

Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment

Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities

Phosphorus May Induce Phenotypic Transdifferentiation of Vascular Smooth Muscle Cells through the Reduction of microRNA-145

Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure

RICORS2040: the need for collaborative research in chronic kidney disease

CKD: The burden of disease invisible to research funders

A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D—a randomised multicentre international clinical trial

Vitamin D Treatment Prevents Uremia-Induced Reductions in Aortic microRNA-145 Attenuating Osteogenic Differentiation despite Hyperphosphatemia

Contribución de fósforo y PTH al desarrollo de hipertrofia y fibrosis cardíaca en un modelo experimental de insuficiencia renal crónica

Collaborators (8)

Manuel A Fernandez-Rodriguez

Juan F. Navarro-González

Armando Torres

GUILLERMO MARIÑO GARCÍA

SONIA MOTA

Laura Vicente Vicente

Julio Alvarez-Builla

Marcos Perez

Make your next move.